Skip to content

LBRX LBRX Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Alkermes logo
AlkermesALKS
2.6%-4.0pp
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-23.1%
Alto Neuroscience logo
Alto NeuroscienceANRO
-10.3%-4.9pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
22.7%+15.1pp
Opko Health logo
Opko HealthOPK
-24.6%-29.5pp

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$888.98M+163%
Enterprise value$571.77M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Calculated from LBRX’s reported figures.

Based on trailing twelve months.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's earnings yield?
LBRX (LBRX) reported earnings yield of -5.5% in Q1 2026.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.